RxDoctor Payments DataLook up a doctor →

Neil Farris

Internal Medicine · Lexington, KYNPI 1053304139

Payments from drug & device makers

$3,010,025in general payments, 2019–2025

Across 3,165 payments — averaging $951.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk AS$925K
  • AbbVie$602K
  • Sanofi US Services Inc.$580K
  • Amgen$467K
  • Kowa Research Institute, Inc.$340K
  • Novartis$52K
  • plus $43K from 5 others
$7,218in research payments, 2019–2025

Across 4 payments — averaging $1804.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$7K
  • Novo Nordisk$48

General payments by program year

19
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk AS2,971$925,441
AbbVie63$601,924
Sanofi US Services Inc.43$580,237
Amgen34$467,365
Kowa Research Institute, Inc.40$339,821
Novartis4$51,738
GSK4$28,772
Pfizer1$6,000
AstraZeneca1$5,272
Swedish Orphan Biovitrum AB1$3,358
Novo Nordisk3$97

How this compares

$3,010,025 in reported general payments places this provider in the 95th percentile of 1,284 internal medicine providers in Kentucky.

See all internal medicine providers in Kentucky

Other internal medicine in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →